Cumberland Pharmaceuticals
CPIX
46 hedge funds and large institutions have $36.4M invested in Cumberland Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 6 closing their positions.
17% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 6
6% more capital invested
Capital invested by funds: $34.2M → $36.4M (+$2.15M)
2% more funds holding
Funds holding: 45 → 46 (+1)
0% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 12
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
+$345K |
| 2 |
Renaissance Technologies
New York
|
+$308K |
| 3 |
Invesco
Atlanta,
Georgia
|
+$217K |
| 4 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
+$213K |
| 5 |
EGA
Eagle Global Advisors
Houston,
Texas
|
+$156K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
Ariel Investments
Chicago,
Illinois
|
-$1.11M |
| 2 |
GHA
GW Henssler & Associates
Kennesaw,
Georgia
|
-$693K |
| 3 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
-$235K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$217K |
| 5 |
Millennium Management
New York
|
-$187K |
CPIX Hedge Fund Activity: Q1 2015 in Review
46 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q1 2015, worth a combined $36.4M — up 6.3% from $34.2M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CPIX positions and 6 closed out — a net gain of 1 holder — while 12 added to existing stakes and 12 trimmed.
The largest buyer was Acadian Asset Management, adding an estimated $345K. The largest seller was Ariel Investments, cutting an estimated $1.11M.
- 46 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q1 2015, up from 45 in Q4 2014.
- Funds reported $36.4M of Cumberland Pharmaceuticals stock for Q1 2015, up 6.3% quarter-over-quarter.
- 7 funds opened new Cumberland Pharmaceuticals positions in Q1 2015 and 6 closed out, a net change of +1 holder.
- The largest Cumberland Pharmaceuticals buyer in Q1 2015 was Acadian Asset Management, an estimated $345K added.
- The largest Cumberland Pharmaceuticals seller in Q1 2015 was Ariel Investments, an estimated $1.11M sold.
Based on aggregated 13F filings for Q1 2015.